GLUcose COntrol Safety & Efficacy in type 2 DIabetes, a systematic review and NETwork meta-analysis.

Autor: Guillaume Grenet, Shams Ribault, Giao Bao Nguyen, Faustine Glais, Augustin Metge, Thomas Linet, Behrouz Kassai-Koupai, Catherine Cornu, Théodora Bejan-Angoulvant, Sylvie Erpeldinger, Rémy Boussageon, Aurore Gouraud, Fabrice Bonnet, Michel Cucherat, Philippe Moulin, François Gueyffier

Publikováno v: PLoS ONE, Vol 14, Iss 6, p e0217701 (2019)

BackgroundThe last international consensus on the management of type 2 diabetes (T2D) recommends SGLT-2 inhibitors or GLP-1 agonists for patients with clinical cardiovascular (CV) disease; metformin remains the first-line glucose lowering medication.

Externí odkaz: https://doaj.org/article/b80e052c1b1248caae71b05d7b6683f6

Protocol of GLUcose COntrol Safety and Efficacy in type 2 DIabetes, a NETwork meta-analysis: GLUCOSE DINET protocol-Rational and design

Autor: Augustin Metge, Michel Cucherat, Gia Bao Nguyen, François Gueyffier, Thomas Linet, Catherine Cornu, Guillaume Grenet, Shams Ribault, A. Lajoinie, Philippe Moulin

Publikováno v: Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2017, 31 (3), pp.258-264. ⟨10.1111/fcp.12263⟩
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, 2017, 31 (3), pp.258-264. ⟨10.1111/fcp.12263⟩

International audience; The aim of this study was to propose a ranking of the currently available antidiabetic drugs, regarding vascular clinical outcomes, in patients with type 2 diabetes, through a network meta-analysis approach. Randomized clinica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02859bf104a4110adc06e31d223da610
https://pubmed.ncbi.nlm.nih.gov/28036112